Characterization of GP35 a T Cell Signalling Molecule

Bell, Gregory M.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Physician Scientist Award (K11)
• Project #: 5K11AI000999-03
• Application #: 3085398
• Study Section: Allergy & Clinical Immunology-1 (AITC)
• Project Start: 1990-09-30
• Project End: 1995-08-31
• Budget Start: 1992-09-01
• Budget End: 1993-08-31
• Support Year: 3
• Fiscal Year: 1992

Institution

• Name: University of California San Francisco
• Type: Schools of Medicine
• DUNS #: 073133571
• City: San Francisco
• State: CA
• Country: United States
• Zip Code: 94143

Publications

Bell, G M; Fargnoli, J; Bolen, J B et al. (1996) The SH3 domain of p56lck binds to proline-rich sequences in the cytoplasmic domain of CD2. J Exp Med 183:169-78

Bell, G M; Dethloff, G M; Imboden, J B (1993) CD45-negative mutants of a rat natural killer cell line fail to lyse tumor target cells. J Immunol 151:3646-53

Bell, G M; Bolen, J B; Imboden, J B (1992) Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol Cell Biol 12:5548-54

Bell, G M; Seaman, W E; Niemi, E C et al. (1992) The OX-44 molecule couples to signaling pathways and is associated with CD2 on rat T lymphocytes and a natural killer cell line. J Exp Med 175:527-36